LOCAL MAGNETIZATION SPOILING USING A GRADIENT INSERT FOR REDUCING THE FIELD OF VIEW IN MAGNETIC RESONANCE IMAGING
US Application 60/043,292
Filed on 1997-04-11
Filed on 1997-04-11
PINPOINT METHODS FOR CLEAVING, AMPLIFYING AND ISOLATING NUCLEIC ACIDS IN VIVO
US Application 60/080,234
Filed on 1997-04-03
Filed on 1997-04-03
ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD
US Application 60/021,204
Filed on 1996-07-03
Filed on 1996-07-03
USE OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) IN THE TREATMENT OF ATHEROSCLEROSIS
US Application 60/006,400
Filed on 1995-11-09
Filed on 1995-11-09
METHOD OF IDENTIFYING INHIBITORS OF THE JAK-STAT SIGNAL TRANSDUCTION PATHWAY
US Application 60/000,971
Filed on 1995-07-07
Filed on 1995-07-07
METHOD AND SYSTEM FOR MAGNETIC RESONANCE IMAGING OF FIELDS IN DIELECTRIC MATERIALS
US Application 60/002,505
Filed on 1995-08-18
Filed on 1995-08-18
Detection Of Mutational Frequency In Human Bone Marrow By Sequencing Of Mitochondrial DNA From Single Cells
US Application 60/463,077
Filed on 2003-04-14
Filed on 2003-04-14
One-Time Gene Therapy for hemophilia B
The Licensing Executives Society (LES) has recognized with its “Deals of Distinction” Award licenses granted by the NIH intramural research program to uniCure N.V. based in Amsterdam along with its global partner CSL Behring. As a result of these licenses on November 22, 2022, the U.S. Food and Drug Administration approved Hemgenix®, the world’s first gene therapy for hemophilia B. It represents an historic achievement based on more than a two decades of research and clinical development through a government /industry partnership and license agreements.
SYSTEM AND METHOD FOR VARIABLE-FLIP-ANGLE 3D SPIRAL-IN-OUT TSE/SPACE
Patent Cooperation Treaty
PCT/US2024/010067
Filed on 2024-01-02
PCT/US2024/010067
Filed on 2024-01-02
System and Method for Variable-flip-angle 3D Spiral-in-out TSE/SPACE Using Echo-reordering and Concomitant Gradient Compensation
US Application 18/402,593
Filed on 2024-01-02
Filed on 2024-01-02